RTTNews | Jul 29, 2021 06:02PM EDT

18:02 Thursday, July 29, 2021 (RTTNews.com) - Vertex Pharmaceuticals Inc. (VRTX) lifts its full year 2021 revenue outlook. The company now expects revenues of $7.2 billion to $7.4 billion for the full year 2021.

Analysts polled by Thomson Reuters currently expect revenues of $6.99 billion for the year. Previously, the company expected revenues of $6.7 billion to $6.9 billion.

Meanwhile, the company maintained its outlook for combined R&D and SG&A expenses for the full year of $3.8 billion to $3.95 billion.

Read the original article on RTTNews ( https://www.rttnews.com/3213823/vertex-pharmaceuticals-lifts-fy21-revenue-outlook.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved